Stockreport

Bioverativ: Advancing Hemophilia Treatments [Seeking Alpha]

BIOVERATIV INC COMMON  (BIVV) 
Last bioverativ inc common earnings: 2/13 04:15 pm Check Earnings Report
PDF Summary Bioverativ ( BIVV ) is a recent spin-off from Biogen Idec ( BIIB ), which focuses on rare blood diseases, primarily hemophilia. Their products ELOCTATE and [Read more]